It is used as a pharmaceutical intermediate.
Morihiro Mitsuya.; Kensuke Kobayashi.; Kumiko Kawakami.; Atsushi Satoh.; Yoshio Ogino.; Taro Kakikawa.; Norikazu Ohtake.; Toshifumi Kimura.; Hiroyasu Hirose.; Akio Sato.; Tomosige Numazawa.;Takuro Hasegawa.; Kazuhito Noguchi.; Toshiaki Mase. A Potent, Long-Acting, Orally Active (2R)-2-[(1R)-3,3-Difluorocyclopentyl]-2-hydroxy-2-phenylacetamide:? A Novel Muscarinic M3 Receptor Antagonist with High Selectivity for M3 over M2 Receptors. J. Med. Chem. 2000, 43 (26),5017-5029.
Evan G. Robertson.; Matthew R. Hockridge.; Peter D. Jelfsa.; John P. Simons. IR-UV ion-depletion and fluorescence spectroscopy of2-phenylacetamide clusters: hydration of a primary amide. Phys. Chem. Chem. Phys. 2001, 3 (5),786-795.
Hazard Statements: H302-H319
Harmful if swallowed. Causes serious eye irritation.
Precautionary Statements: P280i-P264-P305+P351+P338-P301+P312a-P337+P313-P501a
Wear eye/face protection. Wash thoroughly after handling. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. IF SWALLOWED: If eye irritation persists: Get medical advice/attention. Dispose of contents/container in accordance with local/regional/national/international regulations.